The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 11 of the 44 sources its claims cite were checked for support.
Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene
Open accessAbstract
Limb-girdle muscular dystrophy type 2H (LGMD2H) is a mild autosomal recessive myopathy that was first described in the Manitoba Hutterite population. Previous studies in our laboratory mapped the causative gene for this disease to a 6.5-Mb region in chromosomal region 9q31-33, flanked by D9S302 and D9S1850. We have now used additional families and a panel of 26 microsatellite markers to construct haplotypes. Twelve recombination events that reduced the size of the candidate region to 560 kb were identified or inferred. This region is flanked by D9S1126 and D9S737 and contains at least four genes. Exons of these genes were sequenced in one affected individual, and four sequence variations were identified. The families included in our study and 100 control individuals were tested for these variations. On the basis of our results, the mutation in the tripartite-motif-containing gene (TRIM32) that replaces aspartate with asparagine at position 487 appears to be the causative mutation of LGMD2H. All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls. This mutation occurs in an NHL (named after the proteins NCL1, HT2A, and LIN-41) domain at a position that is highly conserved. NHL domains are known to be involved in protein-protein interactions. Although the function of TRIM32 is unknown, current knowledge of the domain structure of this protein suggests that it may be an E3-ubiquitin ligase. If proven, this represents a new pathogenic mechanism leading to muscular dystrophy.
Overview
CoChat Summary
## TL;DR
The paper fine-maps the autosomal recessive LGMD2H locus in Manitoba Hutterite families from a 6.5 Mb interval to 560 kb and identifies TRIM32 D487N as the most likely disease-causing mutation. The authors propose that TRIM32 may function as an E3 ubiquitin ligase, suggesting a novel ubiquitin-proteasome mechanism for muscular dystrophy.
## Key findings
- Haplotype analysis in six interrelated Hutterite families identified 12 recombination events that reduced the LGMD2H candidate region from 6.5 Mb to 560 kb, flanked by D9S1126 and D9S737.
- Sequencing of the genes in this interval found four sequence variations; the best candidate was TRIM32 c.1459G>A (p.D487N).
- The paper reports that all 35 affected individuals with LGMD2H were homozygous for V4(Asn)/D487N, and the mutation was not observed in 100 controls.
- The altered residue lies in the third NHL domain of TRIM32 and is one of the two most highly conserved positions in that domain; the authors also state that TRIM32 shows two transcript sizes, 3.3 and 2.5 kb, and is expressed in skeletal muscle.
## Methods
- Studied 35 clinically affected Hutterite patients and their immediate families; genotypes were obtained for 117 individuals across six interrelated families, with 100 controls used for comparison.
- Performed haplotype analysis using 22 additional microsatellite markers to refine the disease interval, then used SSCA, DNA sequencing, and PCR/restriction assays to screen candidate genes and sequence variants.
- Assessed TRIM32 expression with a 12-tissue northern blot and used RT-PCR on RNA from cultured skin fibroblasts to examine whether the PAPPA silent variant affected splicing.
## Limitations
- The paper explicitly notes that the information they possessed did not exclude the possibility that V3 may contribute additional effects to the phenotype.
- They also state that they cannot exclude the possibility that V3 affects an exonic splicing enhancer active only in muscle or mRNA secondary structure; this is a stated uncertainty.
- Evident from the text: the causal claim is based on genetic segregation, absence in controls, and domain conservation, but the paper does not provide functional proof that TRIM32 D487N alters ubiquitin-ligase activity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 4 Not valid · 19 Not checked · 55 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“TRIM32 has, from N- to C-terminal ends, a RINGfinger domain, a B1 box, a coiled-coil domain, and six NHLdomains”
What the sources say
- Could not verifycites Apweiler et al. 2001 sourceExperimental — accuracy not yet measured
The Integration Methods section (p. 2) explains how InterPro describes domains in multidomain proteins, but it does not describe TRIM32. Searches for TRIM32, RING finger, B1 box, coiled-coil, and NHL domains found no passage establishing the claimed domains, their order, or the count of six. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The V3(T) allele was found to have a frequency of 2% in controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three recombination events were identified in individuals C-06, C-07, and E-11, thereby reducing the candidate region from 6.5 Mb to an interval of 713 kb flanked by D9S241 and D9S931 (fig. 1).”
plainstates a causen = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SSCA of exons located between the flanking microsatellitemarkers D9S1126 and D9S737 revealed only one silent substitution (i.e., V3) in PAPPA.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 86 claims and every source verdict.
- Probably not a substantial claim. 40
- It may state two separate claims as one. 25
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Subjects and Methods
“Table 1 Four Sequence Variations Found in Exons within the LGMD2H Candidate Region”
§ Mutation Screening
“V1, an 11-bp deletion in intron 2 of PAPPA, can be excluded as the disease-causing mutation, because it does not segregate with LGMD2H and is outside the candidate region as defined by an inferred ancestral recombination event (in individual E-23; fig. 2).”
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“Parkin, the product of PARK2, is known to be a RINGfinger–containing E3-Ub ligase (Shimura et al. 2000).”
BackgroundThe tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249
Apweiler, R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.37 · Cited by 1,079
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Slack, F. J., Basson, M., Liu, Z., Ambros, V., Horvitz, H. R., & Ruvkun, G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80245-2 · Cited by 751
Cited by
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Hatakeyama, S. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3139 · Cited by 802
“Point mutations in the human TRIM32 gene have been reported in two genetic disorders: limb-girdle muscular dystrophy type 2H (LGMD2H”
BackgroundTRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases
Meroni, G., & Diez‐Roux, G. (2005) · BioEssays · doi:10.1002/bies.20304 · Cited by 730
“mutated in Limb-Girdle Muscular Dystrophy type 2H (LGMD2H).((68)) In other cases of TRIM/RBCC genes involved in human diseases, the physiological targets and the pathogenesis of the symptoms are unknown.”
BackgroundSignaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555
“Loss of desmin is responsible for a particular form of limb girdle muscular dystrophy (Frosk et al., 2002).”
Background
Metadata
- Authors
- Frosk, P., Weiler, T., Nylen, E., Sudha, T., Greenberg, C. R., Morgan, K., Fujiwara, T. M., & Wrogemann, K.
- Affiliations
- University of Manitoba (CA)
- Research Institute of the McGill University Health Centre (CA)
- Corresponding author
- Wrogemann, Klaus
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 70
- Issue
- 3
- Pages
- 663-672
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC447621
- OpenAlex
- W2024140773
- Semantic Scholar
- 2761196aa5154b43901a405f8b3d734bf576cfe7
- Cited by
- 261
- References
- 34
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 18 · 2013: 16 · 2012: 17
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4158 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- TRIM32, E3 ubiquitin ligase, autosomal recessive myopathy, haplotype mapping, candidate gene mapping, protein-protein interaction
- MeSH terms
- Tripartite Motif Proteins, Amino Acid Sequence, Animals, DNA Mutational Analysis, Ethnicity, Exons, Female, Genetic Testing, Haplotypes, Homozygote, Humans, Ligases, Male, Manitoba, Molecular Sequence Data, Muscular Dystrophies, Mutation, Pedigree, RNA, Messenger, Transcription Factors, Consensus Sequence, Sequence Alignment, Protein Structure, Tertiary, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene. https://app.cochat.ai/papers/10.1086/339083
- The paper
- Frosk, P., Weiler, T., Nylen, E., Sudha, T., Greenberg, C. R., Morgan, K., Fujiwara, T. M., & Wrogemann, K. (2002). Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene. The American Journal of Human Genetics. https://doi.org/10.1086/339083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.